Related Experiment Video
Updated: Feb 17, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Biomarkers in connective tissue diseases.
Neelakshi R Jog1, Judith A James2
1Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Okla.
Biomarkers, including autoantibodies, are crucial for diagnosing and managing autoimmune connective tissue diseases like lupus and rheumatoid arthritis. New biomarkers and personalized approaches improve disease monitoring and treatment selection.
Area of Science:
- Rheumatology
- Immunology
- Clinical Diagnostics
Background:
- Autoimmune connective tissue diseases (ACTDs) exhibit significant clinical variability, necessitating reliable biomarkers.
- Current biomarkers, such as autoantibodies and soluble mediators, correlate with clinical features and disease progression.
- Limited biomarker specificity exists due to disease overlap, highlighting the need for improved diagnostic and prognostic tools.
Purpose of the Study:
- To review current biomarkers for major systemic autoimmune connective tissue disorders.
- To discuss newly proposed biomarkers for disease onset and progression.
- To explore novel approaches for personalized monitoring and treatment in ACTDs.
Main Methods:
- Literature review of existing and emerging biomarkers.
- Analysis of biomarker utility in systemic lupus erythematosus, rheumatoid arthritis, systemic sclerosis, and anti-neutrophil cytoplasmic antibody-associated vasculitides.
- Discussion of innovative strategies for patient stratification and personalized medicine.
Main Results:
- Established biomarkers aid in diagnosis and treatment selection for key ACTDs.
- Emerging biomarkers show promise for earlier detection and tracking of disease stages.
- Personalized approaches are being developed to address patient heterogeneity.
Conclusions:
- Biomarkers are essential for comprehensive management of autoimmune connective tissue diseases.
- Continued research into novel biomarkers and personalized strategies will enhance patient outcomes.
- Addressing biomarker limitations is key to advancing the care of patients with ACTDs.
Related Concept Videos
Introduction to Connective Tissues
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Connective Tissue Cell Types
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Extracellular Matrix
Classification of Connective Tissues
Connective Tissue Proper
Connective tissue proper is the most abundant class of connective tissues. As its name implies, it predominantly connects different tissues in the body. Depending on the cell types, ground substance, viscosity, and fiber types in the ECM, connective tissue proper is further categorized into loose and dense....

